Very clear synergistic tumor‐eradicating responses were observed in directly injected tumors when 17D is combined with systemic anti‐CD137 mAb (Melero et al, 1997) that was almost ineffective by itself (Fig 3B). The gene discussed is TNFRSF9; the disease is neoplasm.